Longduoduo CO LTD (LDDD) — SEC Filings

Overview

Longduoduo CO LTD (LDDD) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 12, 2025: Longduoduo Co Ltd (LDDD) reported a significant increase in net loss for the three months ended September 30, 2025, reaching $111,182, a 86.8% increase from $59,504 in the same period of 2024. Total revenues, net, decreased by 14.4% to $658,764 from $769,072 year-over-year, primarily driven by a dro

Sentiment Summary

Across 17 filings, the sentiment breakdown is: 2 bearish, 15 neutral. The dominant filing sentiment for Longduoduo CO LTD is neutral.

Filing Type Overview

Longduoduo CO LTD (LDDD) has filed 6 10-Q, 2 10-K, 6 8-K, 2 DEF 14A, 1 8-K/A with the SEC between Jan 2024 to Nov 2025.

Filings by Year

2025 · 2024

Recent Filings (17)

• Longduoduo's Net Loss Widens 87% Amid Revenue Decline — 10-Q · Nov 12, 2025 Risk: high
  Longduoduo Co Ltd (LDDD) reported a significant increase in net loss for the three months ended September 30, 2025, reaching $111,182, a 86.8% increase from $59
• Longduoduo's China Operations Face Regulatory Headwinds, Distribution Hurdles — 10-K · Sep 26, 2025 Risk: high
  Longduoduo Co Ltd (LDDD) is a Nevada-incorporated holding company that conducts all its business operations through seven subsidiaries located in the People's R
• Longduoduo Co Ltd Files Q1 2025 10-Q — 10-Q · May 14, 2025 Risk: low
  Longduoduo Co Ltd filed its quarterly report (10-Q) for the period ending March 31, 2025. The company, registered in Nevada, operates within the health services
• Longduoduo Co Ltd Files 8-K — 8-K · Apr 11, 2025 Risk: low
  Longduoduo Co Ltd filed an 8-K on April 11, 2025, reporting other events and financial statements as of April 2, 2025. The filing details the company's principa
• Longduoduo Co Ltd Files 8-K on Security Holder Vote Matters — 8-K · Mar 10, 2025 Risk: low
  On March 10, 2025, Longduoduo Co Ltd filed an 8-K report indicating a submission of matters to a vote of security holders. The filing details the company's inco
• Longduoduo Co Ltd Files Q4 2024 10-Q Report — 10-Q · Feb 14, 2025 Risk: low
  Longduoduo Co Ltd filed its quarterly report on February 14, 2025, for the period ending December 31, 2024. The company, incorporated in Nevada, operates in the
• Longduoduo Files Definitive Proxy Statement — DEF 14A · Jan 15, 2025 Risk: low
  Longduoduo Company Limited filed a Definitive Proxy Statement (DEF 14A) on January 15, 2025, for the fiscal year ending June 30, 2025. The filing, identified by
• Longduoduo Files 8-K with Bylaw Amendments and Financials — 8-K · Dec 31, 2024 Risk: low
  Longduoduo Company Limited filed an 8-K on December 30, 2024, reporting amendments to its articles of incorporation or bylaws and filing financial statements an
• Longduoduo Co Ltd Files Q3 2024 10-Q — 10-Q · Nov 14, 2024 Risk: low
  Longduoduo Co Ltd filed its 10-Q for the quarterly period ended September 30, 2024. The company, incorporated in Nevada, is based in Inner Mongolia, P.R. China,
• Longduoduo Co Ltd Files 2024 Annual Report — 10-K · Oct 15, 2024 Risk: low
  Longduoduo Co Ltd filed its annual report (10-K) for the fiscal year ended June 30, 2024. The company, incorporated in Nevada, operates in the health services s
• Longduoduo Co Ltd Reports Director Departure and Officer Appointment — 8-K · Sep 30, 2024 Risk: medium
  Longduoduo Co Ltd announced on September 25, 2024, changes in its board and officer composition. The company reported the departure of a director and the appoin
• Longduoduo Co Ltd Changes Independent Accountant — 8-K · Aug 16, 2024 Risk: medium
  Longduoduo Co Ltd announced on August 12, 2024, a change in its certifying accountant. The company has dismissed its previous independent registered public acco
• Longduoduo Co Ltd Files 10-Q for Period Ended March 31, 2024 — 10-Q · May 9, 2024 Risk: low
  Longduoduo Co Ltd (LDDD) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Longduoduo Co Ltd filed a 10-Q report for the quarterly period ended March
• Longduoduo Co Ltd Files 8-K/A Amendment — 8-K/A · Mar 27, 2024 Risk: low
  Longduoduo Co Ltd filed an amendment (8-K/A) on March 27, 2024, to a previous report originally dated June 16, 2023. This amendment pertains to changes in the r
• Longduoduo Files 8-K on Shareholder Votes — 8-K · Feb 29, 2024 Risk: low
  Longduoduo Company Limited filed an 8-K on February 29, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain spec
• Longduoduo Co Ltd Files 10-Q for Period Ended December 31, 2023 — 10-Q · Feb 7, 2024 Risk: low
  Longduoduo Co Ltd (LDDD) filed a Quarterly Report (10-Q) with the SEC on February 7, 2024. Longduoduo Co Ltd filed a 10-Q report for the quarterly period ended
• Longduoduo Company Limited Announces Annual Meeting on February 29, 2024 — DEF 14A · Jan 12, 2024 Risk: low
  Longduoduo Co Ltd (LDDD) filed a Proxy Statement (DEF 14A) with the SEC on January 12, 2024. Annual Meeting of Shareholders scheduled for February 29, 2024, at

Risk Profile

Risk Assessment: Of LDDD's 17 recent filings, 2 were flagged as high-risk, 2 as medium-risk, and 13 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Longduoduo CO LTD's most recent 10-Q filing (Nov 12, 2025):

• Revenue: $658,764
• Net Income: $-111,182
• EPS: N/A
• Debt-to-Equity: N/A
• Cash Position: $1,247,296
• Operating Margin: N/A
• Total Assets: $1,899,291
• Total Debt: N/A

Key Executives

• Mr. Zhang Liang

Industry Context

Longduoduo operates in the preventive healthcare solutions sector, providing services and products through a network of third-party providers. The company also engages in agent sales of preventive healthcare solutions, earning commissions. The industry is characterized by increasing demand for health and wellness services, but also faces competition from established healthcare providers and emerging digital health platforms.

Top Tags

10-Q (5) · corporate-governance (5) · health-services (4) · quarterly-report (3) · filing (2) · financial-reporting (2) · auditor-change (2) · Quarterly Report (2) · Emerging Growth Company (2) · healthcare (1)

Key Numbers

• Net loss for Q3 2025: $111,182 — Increased 86.8% from $59,504 in Q3 2024
• Total revenues, net for Q3 2025: $658,764 — Decreased 14.4% from $769,072 in Q3 2024
• Revenue concentration from one customer: 99.1% — For the three months ended September 30, 2025
• Cash and cash equivalents at September 30, 2025: $1,247,296 — Decreased 24.1% from $1,642,721 at June 30, 2025
• Net cash used in operating activities for Q3 2025: $374,184 — Improved from $534,998 in Q3 2024
• Shares of common stock outstanding: 30,015,036 — As of September 30, 2025
• Cash in excess of insured amount in China: $848,390 — As of September 30, 2025
• Cost of revenue concentration from Supplier A: 51% — For the three months ended September 30, 2025
• Accounts payable concentration from Supplier D: 90% — As of September 30, 2025
• Aggregate market value of voting stock held by non-affiliates: $79,322,230 — as of December 31, 2024
• Number of PRC operating subsidiaries: 7 — all business operations are conducted through these entities
• Consecutive years of non-inspection by PCAOB: 2 — trigger for potential delisting under HFCAA
• Minimum after-tax profit allocation to statutory reserve: 10% — required for PRC subsidiaries annually
• Statutory reserve cap as percentage of registered capital: 50% — for PRC subsidiaries
• Potential PRC withholding tax rate on dividends: 10.0% — if Longduoduo is considered a PRC tax resident enterprise

Frequently Asked Questions